BioVie Inc. Proceeds from (Repayments of) Debt
BioVie Inc. (BIVI) reported Proceeds from (Repayments of) Debt of -$244.30 thousand for the 12-month period ending 2019-06-30, per its 10-K/A filed 2020-08-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfDebt · last filed 2020-08-07
- BioVie Inc. proceeds from (repayments of) debt for the quarter ending 2019-06-30 was $0.00.
- BioVie Inc. proceeds from (repayments of) debt for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- BioVie Inc. proceeds from (repayments of) debt for the quarter ending 2018-12-31 was $264.00K.
- BioVie Inc. proceeds from (repayments of) debt for the quarter ending 2018-09-30 was -$508.30K.
- BioVie Inc. proceeds from (repayments of) debt for fiscal 2019 was -$244.30K.
- BioVie Inc. proceeds from (repayments of) debt for fiscal 2018 was -$35.00K.
| Period end | Proceeds from (Repayments of) Debt 3 month | Proceeds from (Repayments of) Debt 6 month | Proceeds from (Repayments of) Debt 9 month | Proceeds from (Repayments of) Debt 12 month |
|---|---|---|---|---|
| 2019-06-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-07 | $0.00 derived: sum of 2 quarters · filed 2020-08-07 | $264.00K derived: sum of 3 quarters · filed 2020-08-07 | -$244.30K 10-K/A · filed 2020-08-07 |
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-13 | $264.00K derived: sum of 2 quarters · filed 2020-05-13 | -$244.30K 10-Q · filed 2020-05-13 | -$269.30K derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $264.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-13 | -$244.30K 10-Q · filed 2020-02-13 | -$269.30K derived: sum of 3 quarters · filed 2020-02-13 | -$244.30K derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-09-30 | -$508.30K 10-Q · filed 2019-11-19 | -$533.30K derived: sum of 2 quarters · filed 2019-11-19 | -$508.30K derived: sum of 3 quarters · filed 2019-11-19 | |
| 2018-06-30 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | $0.00 derived: sum of 2 quarters · filed 2019-09-27 | -$35.00K 10-K · filed 2019-09-27 | |
| 2018-03-31 | $25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10 | -$10.00K 10-Q · filed 2019-05-10 | ||
| 2017-12-31 | -$35.00K 10-Q · filed 2019-02-12 | |||
| 2016-12-31 | $10.50K 10-Q · filed 2017-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |